dilazep has been researched along with Chronic Disease in 5 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis." | 7.73 | Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005) |
| "The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis." | 3.73 | Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005) |
| "Systolic intervals, heart rate (HR) and blood pressure (BP) were monitored before and after oral administration of dilazep in 28 patients with chronic coronary disease." | 3.66 | [Cardiodynamic changes induced with dilazep in chronic coronary insufficiency]. ( Fogari, R, 1980) |
| "Adenosine is known to be an endogenous cardioprotective substance." | 2.69 | Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. ( Funaya, H; Hori, M; Kitakaze, M; Komamura, K; Koretsune, Y; Kuzuya, T; Minamino, T; Node, K, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satonaka, H | 1 |
| Suzuki, E | 1 |
| Hayakawa, H | 1 |
| Nishimatsu, H | 1 |
| Nagata, D | 1 |
| Oba, S | 1 |
| Kamijo, A | 1 |
| Takeda, R | 1 |
| Takahashi, M | 1 |
| Yamamoto, Y | 1 |
| Kimura, K | 1 |
| Hirata, Y | 1 |
| Morozumi, K | 2 |
| Sohmiya, S | 1 |
| Kobayashi, M | 1 |
| Sato, M | 1 |
| Fujinami, T | 1 |
| Yoshida, A | 1 |
| Gotoh, I | 1 |
| Fogari, R | 1 |
| Kitakaze, M | 1 |
| Minamino, T | 1 |
| Node, K | 1 |
| Koretsune, Y | 1 |
| Komamura, K | 1 |
| Funaya, H | 1 |
| Kuzuya, T | 1 |
| Hori, M | 1 |
| Takasaki, H | 1 |
| Shibata, M | 1 |
| Ito, S | 1 |
| Kida, H | 1 |
| Iwata, J | 1 |
1 trial available for dilazep and Chronic Disease
| Article | Year |
|---|---|
Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure.
Topics: Adenosine; Adult; Aged; Cardiac Output, Low; Chronic Disease; Dilazep; Dipyridamole; Humans; Middle | 1998 |
4 other studies available for dilazep and Chronic Disease
| Article | Year |
|---|---|
Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Dilazep; Drug Ther | 2005 |
[Clinical effects of dilazep dihydrochloride on glomerulonephritis].
Topics: Adult; Aged; Azepines; Chronic Disease; Dilazep; Female; Glomerulonephritis; Hematuria; Humans; Male | 1983 |
[Cardiodynamic changes induced with dilazep in chronic coronary insufficiency].
Topics: Adult; Aged; Azepines; Chronic Disease; Coronary Disease; Dilazep; Heart; Heart Rate; Humans; Male; | 1980 |
[Long-term effect of dilazep therapy in patients with chronic glomerulonephritis and nephrotic syndrome].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azepines; Child; Child, Preschool; Chronic Disease; Dila | 1987 |